
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Neuroplastogen
Therapeutic Area : Psychiatry/Psychology
Study Phase : Discovery
Sponsor : CRC-P
Deal Size : $3.0 million
Deal Type : Funding
$3M Grant Awarded to Develop Neuroplastogens for Substance Use Treatment
Details : The funding will focus on the development of neuroplastogens for the treatment of substance use disorders, with an emphasis on methamphetamine addiction.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
October 28, 2024
Lead Product(s) : Neuroplastogen
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Discovery
Sponsor : CRC-P
Deal Size : $3.0 million
Deal Type : Funding

Contact Us!